GMI Human Immunodeficiency Virus (HIV)-1 Therapeutics | Page 2

Browse key industry insights from the report “Human Immunodeficiency Virus (HIV)-1
Therapeutics Market Size, Industry Analysis Report, Regional Outlook (U.S., Canada, UK,
Germany, France, Italy, Spain, Japan, China, India, Brazil, Mexico, South Africa),
Application Development Potential, Price Trends, Competitive Market Share & Forecast,
2017 – 2024” in detail along with the table of contents:
https://www.gminsights.com/industry-analysis/human-immunodeficiency-virus-hiv-
1-therapeutics-market
Social stigma, decreasing global funds, discrimination and treatment failures are few
factors hindering the growth of the global human immunodeficiency virus therapeutics
market. Lack of a definitive treatment is a key health issue and results in a high on-going
cost to society.
North America human immunodeficiency virus therapeutics market dominated the
industry in 2016 pertaining to the high incidence and prevalence of HIV/AIDS, growing
awareness about infection, surging government initiatives and blood donations. The U.S.
human immunodeficiency virus therapeutics market is commanded as the greatest
national funder of the HIV epidemic globally.
Asia Pacific human immunodeficiency virus therapeutics market will exhibit profitable
growth, owing to new developments in treatments. Asian manufacturers prove to be a
resilient competition due to their unique patent laws that lead up patent of prerequisite
lifesaving medicines. Also, the prices are doomed to decrease the entry of such
manufacturers, thereby potentially proliferating the industry with regards to volume.
Key industry players include Gilead Sciences, AbbVie, Bristol-Myers Squibb Company,
ViiV Healthcare, and Cipla. Companies focus on innovative product launch and strategic
agreements to expand their business portfolio as main strategies. In April 2016, Gilead
Sciences, announced the FDA approval of Descovy, a fixed-dose combination for the
treatment of HIV, for the treatment of HIV-1 infection.
About Global Market Insights:
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market
research and consulting service provider; offering syndicated and custom research
reports along with growth consulting services. Our business intelligence and industry
research reports offer clients with penetrative insights and actionable market data
specially designed and presented to aid strategic decision making. These exhaustive
reports are designed via a proprietary research methodology and are available for key
industries such as chemicals, advanced materials, technology, renewable energy and
biotechnology.
2 | Page